Guillain-Barre Syndrome (GBS) is a rare neurological disorder that affects the peripheral nervous system. It is characterized by the immune system mistakenly attacking the nerves, leading to muscle weakness and sometimes paralysis.
The exact cause of GBS is unknown, but it often occurs after an infection, such as a respiratory or gastrointestinal infection. The immune response triggered by the infection can result in damage to the myelin sheath, the protective covering of the nerves.
Symptoms of GBS typically start with weakness and tingling sensations in the legs, which then spread to the arms and upper body. In severe cases, muscle weakness can progress to paralysis, affecting breathing and other vital functions.
Diagnosis of GBS involves a thorough physical examination, medical history review, and various tests, including nerve conduction studies and lumbar puncture.
Treatment for GBS focuses on managing symptoms and providing supportive care. This may include intravenous immunoglobulin therapy, plasma exchange, and physical therapy to aid in recovery.
Prognosis for GBS varies, but most individuals experience a gradual recovery over weeks or months. However, some may have long-term complications or require ongoing medical support.